Top Markets
#1 PulseChain PulseChain +45.01%
#2 SkyAI SkyAI +13.25%
#3 Bitway Bitway +11.68%
#4 Glidr Glidr +9.69%
#5 Meteora Meteora +9.51%
#6 OPENLOOT OPENLOOT +8.29%
#7 Unit Pump Unit Pump +8.17%
#8 Pump.fun Pump.fun +8.17%
#9 Lorenzo Wrapped Bitcoin Lorenzo Wrapped Bitcoin +7.80%
#10 eCash eCash +7.48%
Coin of the day
PulseChain PulseChain
Settings
Language
ENGLISH
Currency
USD
Theme
Oncocross Co., Ltd. Oncocross Co., Ltd.

Oncocross Co., Ltd.

382150
Rank in Stocks #27845
Oncocross Co., Ltd. undertakes collaborative research initiatives to discover... Oncocross Co., Ltd. undertakes collaborative research initiatives to discover new drugs, partnering with a variety of pharmaceutical companies both within South Korea and abroad. The company offers a fresh paradigm for drug development by providing analytical insights derived from its advanced artificial intelligence drug discovery platform. Founded by Yi-Rang Kim on June 22, 2015, Oncocross operates from its headquarters located in Seoul, South Korea.
Share Price
$2.50
Market Cap
$30.53M
Change (1 day)
7.26%
Change (1 year)
-59.50%
Country
KR
Trade Oncocross Co., Ltd. (382150)

Category

Healthcare
Revenue for Oncocross Co., Ltd. (382150)
Revenue in Aug 2026 TTM: 0
According to Oncocross Co., Ltd. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Oncocross Co., Ltd. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.70B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH